Company news
3SBio, Inc. news in 2020
3SBio, Inc.'s news releases, calls and decks from 2020, newest first.
3SBio Inc. received milestone payment of USD 4 million upon commencement of phase III clinical program of SEL-212
November 23, 2020
3SBio Announces Acceptance of IND application for bevacizumab biosimilar in China
September 14, 2020
Voluntary announcement - acceptance of the IND application for bevacizumab biosimilar in Mainland China
September 14, 2020
Decks in 2020
- H1 2020 Earnings Presentation
Earnings · 30 slides · Jul 18, 2020
- FY2019 Earnings Presentation
Earnings · 30 slides · Mar 31, 2020